CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C12904 | BRD-K33010769 | SA-244237 | -- | -- | -- | Details |
| C12905 | BRD-K33012050 | BRD-K33012050 | -- | -- | -- | Details |
| C12906 | BRD-K33013391 | BRD-K33013391 | -- | -- | -- | Details |
| C12907 | BRD-K33016067 | BRD-K33016067 | -- | -- | -- | Details |
| C12908 | BRD-K33017576 | BRD-K33017576 | -- | -- | -- | Details |
| C12909 | BRD-K33018174 | BRD-K33018174 | -- | -- | -- | Details |
| C12910 | BRD-K33037101 | BRD-K33037101 | -- | -- | -- | Details |
| C12911 | BRD-K33038714 | BRD-K33038714 | -- | -- | -- | Details |
| C12912 | BRD-K33039006 | BRD-K33039006 | -- | -- | -- | Details |
| C12913 | BRD-K33044659 | BRD-K33044659 | -- | -- | -- | Details |
| C12914 | BRD-K33044853 | BRD-K33044853 | -- | -- | -- | Details |
| C12915 | BRD-K33045404 | BRD-K33045404 | -- | -- | -- | Details |
| C12916 | BRD-K33054146 | BRD-K33054146 | -- | -- | -- | Details |
| C12917 | BRD-K33056518 | BRD-K33056518 | -- | -- | -- | Details |
| C12918 | BRD-K33057338 | BRD-K33057338 | -- | -- | -- | Details |
| C12919 | BRD-K33061098 | BRD-K33061098 | -- | -- | -- | Details |
| C12920 | BRD-K33064128 | BRD-K33064128 | -- | -- | -- | Details |
| C12921 | BRD-K33064169 | BRD-K33064169 | -- | -- | -- | Details |
| C12922 | BRD-K33064989 | BRD-K33064989 | -- | -- | -- | Details |
| C12923 | BRD-K33065959 | BRD-K33065959 | -- | -- | -- | Details |
| C12924 | BRD-K33066317 | BRD-K33066317 | -- | -- | -- | Details |
| C12925 | BRD-K33071234 | BRD-K33071234 | -- | -- | -- | Details |
| C12926 | BRD-K33078666 | BRD-K33078666 | -- | -- | -- | Details |
| C12927 | BRD-K33086940 | JAS07-007 | -- | -- | JAS-07-007 | Details |
| C12928 | BRD-K33095226 | SA-85377 | -- | -- | -- | Details |
| C12929 | BRD-K33098168 | BRD-K33098168 | -- | -- | -- | Details |
| C12930 | BRD-K33102216 | BRD-K33102216 | -- | -- | -- | Details |
| C12931 | BRD-K33104513 | BRD-K33104513 | -- | -- | -- | Details |
| C12932 | BRD-K33106058 | cytarabine | POLA1; POLB | Ribonucleotide reductase inhibitor | -- | Details |
| C12933 | BRD-K33116223 | BRD-K33116223 | -- | -- | -- | Details |
| C12934 | BRD-K33116513 | BRD-K33116513 | -- | -- | -- | Details |
| C12935 | BRD-K33122655 | BRD-K33122655 | -- | -- | -- | Details |
| C12936 | BRD-K33127281 | adapalene | RARA; RARB; RARG | Retinoid receptor agonist | -- | Details |
| C12937 | BRD-K33128056 | BRD-K33128056 | -- | -- | -- | Details |
| C12938 | BRD-K33130522 | BRD-K33130522 | -- | -- | -- | Details |
| C12939 | BRD-K33141550 | L-NAME | -- | -- | l-name | Details |
| C12940 | BRD-K33148516 | BRD-K33148516 | -- | -- | -- | Details |
| C12941 | BRD-K33151492 | BRD-K33151492 | -- | -- | -- | Details |
| C12942 | BRD-K33159591 | BRD-K33159591 | -- | -- | -- | Details |
| C12943 | BRD-K33164466 | BRD-K33164466 | -- | -- | -- | Details |
| C12944 | BRD-K33165698 | BRD-K33165698 | -- | -- | -- | Details |
| C12945 | BRD-K33171119 | BRD-K33171119 | -- | -- | -- | Details |
| C12946 | BRD-K33177501 | BRD-K33177501 | -- | -- | -- | Details |
| C12947 | BRD-K33179234 | BRD-K33179234 | -- | -- | -- | Details |
| C12948 | BRD-K33182644 | BRD-K33182644 | -- | -- | -- | Details |
| C12949 | BRD-K33193182 | methylnorlichexanthone | PIM1; AURKB | VEGFR inhibitor; Pim kinase inhibitor; Aurora kinase inhibitor | -- | Details |
| C12950 | BRD-K33194123 | BRD-K33194123 | -- | -- | -- | Details |
| C12951 | BRD-K33197627 | BRD-K33197627 | -- | -- | -- | Details |
| C12952 | BRD-K33199242 | BRD-K33199242 | -- | -- | -- | Details |
| C12953 | BRD-K33200274 | BRD-K33200274 | -- | -- | -- | Details |
| C12954 | BRD-K33204113 | BRD-K33204113 | -- | -- | -- | Details |
| C12955 | BRD-K33204703 | AG-370 | PDGFRB | PDGFR inhibitor | -- | Details |
| C12956 | BRD-K33204746 | BRD-K33204746 | -- | -- | -- | Details |
| C12957 | BRD-K33211335 | BRD-K33211335 | -- | -- | dextromethorphan | Details |
| C12958 | BRD-K33215066 | BRD-K33215066 | -- | -- | -- | Details |
| C12959 | BRD-K33217094 | BRD-K33217094 | -- | -- | -- | Details |
| C12960 | BRD-K33217566 | BRD-K33217566 | -- | -- | -- | Details |
| C12961 | BRD-K33218695 | BRD-K33218695 | -- | -- | -- | Details |
| C12962 | BRD-K33218708 | BRD-K33218708 | -- | -- | -- | Details |
| C12963 | BRD-K33221810 | BRD-K33221810 | -- | -- | -- | Details |
| C12964 | BRD-K33226370 | BRD-K33226370 | -- | -- | -- | Details |
| C12965 | BRD-K33226500 | indinavir | CYP3A7; CYP3A4; CYP3A5 | HIV protease inhibitor | -- | Details |
| C12966 | BRD-K33230547 | BRD-K33230547 | -- | -- | -- | Details |
| C12967 | BRD-K33235400 | BRD-K33235400 | -- | -- | -- | Details |
| C12968 | BRD-K33236055 | BRD-K33236055 | -- | -- | -- | Details |
| C12969 | BRD-K33236383 | BRD-K33236383 | -- | -- | -- | Details |
| C12970 | BRD-K33238309 | BRD-K33238309 | -- | -- | -- | Details |
| C12971 | BRD-K33240821 | plerixafor | CXCR4 | CCK receptor antagonist | -- | Details |
| C12972 | BRD-K33245965 | BMS-833923 | -- | -- | -- | Details |
| C12973 | BRD-K33251802 | miglustat | UGCG | Glycosyl transferase inhibitor | -- | Details |
| C12974 | BRD-K33257311 | BRD-K33257311 | -- | -- | -- | Details |
| C12975 | BRD-K33258193 | BRD-K33258193 | -- | -- | -- | Details |
| C12976 | BRD-K33258928 | BRD-K33258928 | -- | -- | -- | Details |
| C12977 | BRD-K33260002 | BRD-K33260002 | -- | -- | -- | Details |
| C12978 | BRD-K33263026 | BRD-K33263026 | -- | -- | -- | Details |
| C12979 | BRD-K33268483 | BRD-K33268483 | -- | -- | -- | Details |
| C12980 | BRD-K33269038 | BRD-K33269038 | -- | -- | -- | Details |
| C12981 | BRD-K33272502 | DG-041 | PTGER3 | Prostanoid receptor antagonist | -- | Details |
| C12982 | BRD-K33272704 | BRD-K33272704 | -- | -- | -- | Details |
| C12983 | BRD-K33274327 | BRD-K33274327 | -- | -- | -- | Details |
| C12984 | BRD-K33277808 | ouabain | ATP1A1 | ATPase inhibitor | -- | Details |
| C12985 | BRD-K33283629 | BRD-K33283629 | -- | -- | -- | Details |
| C12986 | BRD-K33284065 | BRD-K33284065 | -- | -- | -- | Details |
| C12987 | BRD-K33287655 | BRD-K33287655 | -- | -- | -- | Details |
| C12988 | BRD-K33297438 | BRD-K33297438 | -- | -- | -- | Details |
| C12989 | BRD-K33299843 | naproxen | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C12990 | BRD-K33303625 | BRD-K33303625 | -- | -- | -- | Details |
| C12991 | BRD-K33305493 | BRD-K33305493 | -- | -- | -- | Details |
| C12992 | BRD-K33308633 | INCA-6 | NFATC1 | Calcineurin inhibitor | -- | Details |
| C12993 | BRD-K33312228 | halometasone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C12994 | BRD-K33312838 | BRD-K33312838 | -- | -- | -- | Details |
| C12995 | BRD-K33314491 | BRD-K33314491 | -- | -- | -- | Details |
| C12996 | BRD-K33318635 | BRD-K33318635 | -- | -- | -- | Details |
| C12997 | BRD-K33324635 | BRD-K33324635 | -- | -- | -- | Details |
| C12998 | BRD-K33326988 | BRD-K33326988 | -- | -- | -- | Details |
| C12999 | BRD-K33328711 | BRD-K33328711 | -- | -- | -- | Details |
| C13000 | BRD-K33336844 | cryptotanshinone | STAT3 | STAT inhibitor; Acetylcholinesterase inhibitor | -- | Details |
| C13001 | BRD-K33341138 | BRD-K33341138 | -- | -- | -- | Details |
| C13002 | BRD-K33346587 | BRD-K33346587 | -- | -- | -- | Details |
| C13003 | BRD-K33348232 | BRD-K33348232 | -- | -- | -- | Details |